SCHEMBL34465680

SCHEMBL34465680

COC(COc1cc2c3n(nc2c(F)c1Cl)[C@@H](C)CN(C(=O)OC(C)(C)C)[C@H]3C)OC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL35212050 0.88 SUV39H2 (0.35) —
SCHEMBL35212051 0.88 SUV39H2 (0.35) —
SCHEMBL35211815 0.88 SUV39H2 (0.35) —
SCHEMBL34465705 0.86 SCN9A (0.31) —
SCHEMBL34466004 0.86 SCN9A (0.31) —
SCHEMBL35212572 0.82 SCN9A (0.31) —
SCHEMBL34465127 0.82 USP30 (0.32) —
SCHEMBL35212331 0.82 USP30 (0.32) —
SCHEMBL34466268 0.82 SCN9A (0.31) —
SCHEMBL34465221 0.82 USP30 (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260109704-A1 5-MEMBERED HETEROARYL INDAZOLE CGAS INHIBITORS AND USES THEREOF VENTUS THERAPEUTICS U.S., INC. (US) 2026-04-23 — — US disclosed
Send feedback